Compare Edgewise Therapeutics Inc. Common Stock (EWTX) vs Microsoft (MSFT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Edgewise Therapeutics Inc. Common Stock vs Microsoft — how do they compare? Edgewise Therapeutics Inc. Common Stock trades at $37.13 (market cap $3.94B), while Microsoft trades at $531.8 (market cap $4.04T). The key difference: Microsoft is far larger — about 1025.4× Edgewise Therapeutics Inc. Common Stock's market cap, and Microsoft pays a 0.72% dividend while Edgewise Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Edgewise Therapeutics Inc. Common Stock for 0 Days and Microsoft for 142 Days on average.
| EWTX | MSFT | |
|---|---|---|
Market Cap | $3.94B | $4.04T |
Volume | 810,104 | 23,799,223 |
Sector | Health | Technology |
52-Week High | $48.35 | $543.45 |
52-Week Low | $14.89 | $352.83 |
Typical Hold Time | 0 Days | 142 Days |
Enterprise Value | $3.48B | $4.02T |
Dividend Yield | — | 0.72% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Microsoft (MSFT) trades at $543.45, up 0.43% with strong technical momentum and bullish moving average signals. The company demonstrates robust fundamentals with Q2 2026 EPS of $4.74 beating estimates of $4.24, continuing a trend of earnings outperformance. Revenue growth accelerated to $281.72B in 2025 with impressive 40.31% net income margin. Analyst consensus remains overwhelmingly positive with 82% buy ratings and $577.52 price target representing 6.3% upside potential.
Microsoft's AI leadership and cloud dominance position it for sustained growth, though elevated P/E of 30.28 and RSI levels near 83 suggest potential near-term consolidation. Key risks include increased capital expenditure pressures and competitive threats in AI infrastructure. The stock offers strong long-term prospects but may face volatility from valuation concerns and macroeconomic headwinds affecting tech sector performance.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Edgewise Therapeutics Inc. Common Stock
Edgewise Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops small-molecule therapies based on its research in muscle physiology, with a pipeline focused on cardiovascular and cardiometabolic conditions such as hypertrophic cardiomyopathy and heart failure.
Read more on EWTX →About Microsoft
Microsoft Corporation develops, manufactures, licenses, sells, and supports software products. The Company offers operating system software, server application software, business and consumer applications software, software development tools, and Internet and intranet software. Microsoft also develops video game consoles and digital music entertainment devices.
Read more on MSFT →
